SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-005171
Filing Date
2019-02-01
Accepted
2019-02-01 17:14:53
Documents
4
Period of Report
2019-02-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-3627_38k.htm 8-K 31427
2 EX-1.1 a19-3627_3ex1d1.htm EX-1.1 393657
3 EX-4.1 a19-3627_3ex4d1.htm EX-4.1 145749
4 EX-5.1 a19-3627_3ex5d1.htm EX-5.1 13780
  Complete submission text file 0001104659-19-005171.txt   585836
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

IRS No.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37990 | Film No.: 19560742
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1